Literature DB >> 24582728

Radiofrequency ablation for colorectal liver metastases.

A Stoltz1, J Gagnière1, A Dupré1, M Rivoire2.   

Abstract

The management of hepatic metastases from colorectal cancer (HMCRC) is multimodal including chemotherapy, surgical resection, radiation therapy, and focused destruction technologies. Radiofrequency ablation (RFA) is the most commonly used focused destruction technology. It represents a therapeutic option that may be potentially curative in cases where surgical excision is contra-indicated. It also increases the number of candidates for surgical resection among patients whose liver metastases were initially deemed unresectable. This article explains the techniques, indications, and results of radiofrequency ablation in the treatment of hepatic colorectal metastases.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Colorectal cancer; Focused destruction; Hepatectomy; Liver metastases; Radiofrequency ablation

Mesh:

Year:  2014        PMID: 24582728     DOI: 10.1016/j.jviscsurg.2013.12.005

Source DB:  PubMed          Journal:  J Visc Surg        ISSN: 1878-7886            Impact factor:   2.043


  7 in total

Review 1.  Colorectal cancer with potentially resectable hepatic metastases: optimizing treatment.

Authors:  Mathias Worni; Kevin N Shah; Bryan M Clary
Journal:  Curr Oncol Rep       Date:  2014-10       Impact factor: 5.075

2.  Phase Contrast Imaging Based Microbubble Monitoring of Radiofrequency Ablation: An ex vivo Study.

Authors:  Wei Huang; Jian Lu; Rongbiao Tang; Zhiyuan Wu; Qingbing Wang; Xiaoyi Ding; Zhongmin Wang; Kemin Chen
Journal:  Front Oncol       Date:  2020-08-25       Impact factor: 6.244

3.  Non-response to preoperative chemotherapy is a contraindication to hepatectomy plus radiofrequency ablation in patients with colorectal liver metastases.

Authors:  Rui Mao; Jian-Jun Zhao; Hong Zhao; Ye-Fan Zhang; Xin-Yu Bi; Zhi-Yu Li; Jian-Guo Zhou; Xiao-Long Wu; Chen Xiao; Jian-Qiang Cai
Journal:  Oncotarget       Date:  2017-09-05

4.  Incomplete radiofrequency ablation provokes colorectal cancer liver metastases through heat shock response by PKCα/Fra-1 pathway.

Authors:  Zhanguo Zhang; Yuxin Zhang; Lei Zhang; Youliang Pei; Yanhui Wu; Huifang Liang; Wanguang Zhang; Bixiang Zhang
Journal:  Cancer Biol Med       Date:  2019-08       Impact factor: 4.248

Review 5.  Local Treatments in the Unresectable Patient with Colorectal Cancer Metastasis: A Review from the Point of View of the Medical Oncologist.

Authors:  Javier Torres-Jiménez; Jorge Esteban-Villarrubia; Reyes Ferreiro-Monteagudo; Alfredo Carrato
Journal:  Cancers (Basel)       Date:  2021-11-25       Impact factor: 6.639

Review 6.  Limited Liver or Lung Colorectal Cancer Metastases. Systemic Treatment, Surgery, Ablation or SBRT.

Authors:  Meritxell Molla; Julen Fernandez-Plana; Santiago Albiol; Constantino Fondevila; Ivan Vollmer; Carla Cases; Angeles Garcia-Criado; Jaume Capdevila; Carles Conill; Yliam Fundora; Carlos Fernandez-Martos; Estela Pineda
Journal:  J Clin Med       Date:  2021-05-14       Impact factor: 4.241

7.  Quantitative Tracking Tumor Suppression Efficiency of Human Umbilical Cord-Derived Mesenchymal Stem Cells by Bioluminescence Imaging in Mice Hepatoma Model.

Authors:  Jingjing Liu; Yupeng Shi; Jing Han; Yong Zhang; Zhenghao Cao; Jingliang Cheng
Journal:  Int J Stem Cells       Date:  2020-03-30       Impact factor: 2.500

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.